Cargando…

White matter changes in empirically derived incident MCI subtypes in the Mayo Clinic Study of Aging

INTRODUCTION: The aim of this study was to examine white matter hyperintensities (WMH) and fractional anisotropy (FA) in empirically derived incident mild cognitive impairment (MCI) subtypes. METHODS: We evaluated 188 participants with incident MCI in the Mayo Clinic Study of Aging (MCSA) identified...

Descripción completa

Detalles Bibliográficos
Autores principales:	Machulda, Mary M., Lundt, Emily S., Mester, Carly T., Albertson, Sabrina M., Raghavan, Sheelakumari, Reid, Robert I., Schwarz, Christopher G., Graff‐Radford, Jonathan, Jack, Clifford R., Knopman, David S., Mielke, Michelle M., Kremers, Walter K., Petersen, Ronald C., Bondi, Mark W., Vemuri, Prashanthi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Neuroimaging
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719426/ https://www.ncbi.nlm.nih.gov/pubmed/35005199 http://dx.doi.org/10.1002/dad2.12269

Ejemplares similares

Cortical atrophy patterns of incident MCI subtypes in the Mayo Clinic Study of Aging
por: Machulda, Mary M., et al.
Publicado: (2020)

Diffusion models reveal white matter microstructural changes with ageing, pathology and cognition
por: Raghavan, Sheelakumari, et al.
Publicado: (2021)

Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors
por: Raman, Mekala R., et al.
Publicado: (2016)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Head injury is associated with tau deposition on PET in MCI and AD patients
por: Risacher, Shannon L., et al.
Publicado: (2021)

Mayo normative studies: A conditional normative model for longitudinal change on the Auditory Verbal Learning Test and preliminary validation in preclinical Alzheimer's disease
por: Alden, Eva C., et al.
Publicado: (2022)

Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging
por: Krell-Roesch, Janina, et al.
Publicado: (2019)

Causal structure discovery identifies risk factors and early brain markers related to evolution of white matter hyperintensities
por: Shen, Xinpeng, et al.
Publicado: (2022)

Study of Symptomatic vs. Silent Brain Infarctions on MRI in Elderly Subjects
por: Raghavan, Sheelakumari, et al.
Publicado: (2021)

Evidence against a temporal association between cerebrovascular disease and Alzheimer’s disease imaging biomarkers
por: Cogswell, Petrice M., et al.
Publicado: (2023)

Amyloid, Vascular, and Resilience Pathways Associated with Cognitive Aging
por: Vemuri, Prashanthi, et al.
Publicado: (2019)

Long-term associations between amyloid positron emission tomography, sex, apolipoprotein E and incident dementia and mortality among individuals without dementia: hazard ratios and absolute risk
por: Jack, Clifford R., et al.
Publicado: (2022)

Cross–scanner harmonization methods for structural MRI may need further work: A comparison study
por: Gebre, Robel K., et al.
Publicado: (2023)

Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Longitudinal deterioration of white-matter integrity: heterogeneity in the ageing population
por: Poulakis, Konstantinos, et al.
Publicado: (2021)

Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes
por: Marks, Jordan D., et al.
Publicado: (2021)

Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures
por: Mielke, Michelle M., et al.
Publicado: (2019)

White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease
por: Tian, Jianqiao, et al.
Publicado: (2023)

Neuropsychiatric symptoms and the outcome of cognitive trajectories in older adults free of dementia: The Mayo Clinic Study of Aging
por: Krell‐Roesch, Janina, et al.
Publicado: (2021)

White matter abnormalities are key components of cerebrovascular disease impacting cognitive decline
por: Vemuri, Prashanthi, et al.
Publicado: (2021)

NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages
por: Petersen, Ronald C., et al.
Publicado: (2021)

Variants in PPP2R2B and IGF2BP3 are associated with higher tau deposition
por: Ramanan, Vijay K, et al.
Publicado: (2020)

Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI
por: Nguyen, Aivi T., et al.
Publicado: (2022)

Association of Apolipoprotein E ɛ4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older Adults
por: Ramanan, Vijay K, et al.
Publicado: (2019)

Relationship Between Risk Factors and Brain Reserve in Late Middle Age: Implications for Cognitive Aging
por: Neth, Bryan J., et al.
Publicado: (2020)

White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition
por: Raghavan, Sheelakumari, et al.
Publicado: (2022)

Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer’s pathophysiology
por: Ramanan, Vijay K., et al.
Publicado: (2021)

Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease
por: Keret, Ophir, et al.
Publicado: (2021)

Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging
por: Krell-Roesch, Janina, et al.
Publicado: (2021)

Cranial nerve schwannoma – A pictorial essay
por: Geethapriya, Sivaramalingam, et al.
Publicado: (2020)

Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive Impairment
por: Vassilaki, Maria, et al.
Publicado: (2023)

Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging
por: Vemuri, Prashanthi, et al.
Publicado: (2018)

Cognitive interventions in Alzheimer's and Parkinson's diseases: emerging mechanisms and role of imaging
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Advancing Tau-PET quantification in Alzheimer’s disease with machine learning: introducing THETA, a novel tau summary measure
por: Gebre, Robel K., et al.
Publicado: (2023)

Longitudinal tau PET in ageing and Alzheimer’s disease
por: Jack, Clifford R, et al.
Publicado: (2018)

Deep learning identifies brain structures that predict cognition and explain heterogeneity in cognitive aging
por: Saboo, Krishnakant V., et al.
Publicado: (2022)

Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging
por: Vassilaki, Maria, et al.
Publicado: (2022)

Memory concerns in the early Alzheimer's disease prodrome: Regional association with tau deposition
por: Swinford, Cecily G., et al.
Publicado: (2018)

The comorbidity and cognition in multiple sclerosis (CCOMS) neuroimaging protocol: Study rationale, MRI acquisition, and minimal image processing pipelines
por: Uddin, Md Nasir, et al.
Publicado: (2022)

Relationships between β-amyloid and tau in an elderly population: An accelerated failure time model
por: Therneau, Terry M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_75iqsupav1m51kn0oecojj4t4s